The number of Risperdal lawsuits consolidated in the Pennsylvania Court of Common Pleas as part of a multidistrict litigation (MDL) surpassed 1,000 this month, according to court reports. As of mid-November, a total of 1,012 Risperdal lawsuits were included in the pending litigation, which suggests a continued increase in the number of complaints brought against Johnson & Johnson over alleged Risperdal gynecomastia side effects and other injuries. If you believe you have been harmed by side effects of Risperdal, such as male breast growth (gynecomastia), consult a knowledgeable Risperdal lawyer today to discuss your legal options.
According to the findings of a new study presented at the Canadian Cardiovascular Congress, many of the most popular antipsychotic medications double the risk of heart attack and triple the risk of stroke for patients taking the controversial drugs. If you have suffered a heart attack, stroke, or another potential side effect of Risperdal, consult a reputable Risperdal lawyer today to explore your possible compensation options. With a knowledgeable Risperdal attorney on your side, you can ensure that your legal rights are protected, and pursue the financial compensation you deserve for your injuries, medical expenses, and pain and suffering.
07 Nov 2014
As Risperdal lawsuits continue to mount in courts across the country, a hearing recently held in Vermont has raised serious concerns about the adherence to pediatric dosing guidelines among doctors who prescribe Risperdal and other powerful antipsychotic drugs to children. According to Dr. David C. Rettew, Director of the Pediatric Psychiatry Clinic at University of Vermont’s College of Medicine, the findings of a new survey suggest that doctors in Vermont adhered to prescribing guidelines established by the American Academy of Child and Adolescent Psychiatry (AACAP) approximately 51% of the time. During a recent testimony before Vermont’s Mental Health Oversight Committee, Dr. Rettew also noted that the same survey showed that doctors in Vermont only followed FDA recommendations on pediatric prescription of antipsychotic drugs about 27% of the time.